DEC 13, 2017 03:03 PM PST

Nanoparticles May Be the Future of Cancer Screening

WRITTEN BY: Xuan Pham

Image credit: Pixabay.com

Despite advances in cancer medicine, we are limited by what we can detect. That is, doctors can’t treat something that they can’t see. And in many cases, by the time the cancer is detectable, the disease becomes harder to treat. Now researchers at Rutgers University say a nanoprobe could give doctors the rare window of opportunity to treat the cancer even before it has been detected by conventional diagnostic methods.

The prognosis of many cancer largely depends on when the cancer is caught. The earlier the diagnosis, the better the odds for the patient. By contrast, cancers detected at the late stages generally have worse outcomes. In fact, about 90% of cancer deaths are attributed to metastatic events.

While they’re improving, the current available methods for cancer detection (scans, X-rays, biopsies) are not always accurate when the cancer is in its earliest stages. But it is exactly this early stage that the research team targeted, as it would arguably give patients the best odds.

The team developed nanoparticles that emit short-wave infrared light when encountering metastatic lesions. This nanoprobe is injected intravenously, and is designed to track cancer metastasis at the smallest level. The team called these small cancerous lesions “microlesions.”

In a mouse model of human breast cancer, the nanoprobes picked up microlesions in the bones and the adrenal glands of the animal. By contrast, the same microlesions were undetected until later with standard magenetic resonance imaging (MRI) techniques.

“We've always had this dream that we can track the progression of cancer in real time, and that's what we've done here. We've tracked the disease in its very incipient stages," said Dr. PrabhasMoghe.

"Cancer cells can lodge in different niches in the body, and the probe follows the spreading cells wherever they go," explained Dr. Vidya Ganapathy, the study’s co-author. "You can treat the tumors intelligently because now you know the address of the cancer."

The team asserted the nanoprobes can detect over 100 different types of cancer. Furthermore, they estimate the nanotechnology may be ready for the clinic in about 5 years.

Additional sources: MNT

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUN 12, 2018
Cell & Molecular Biology
JUN 12, 2018
Loss of Brain Lesions may Indicate Worsening MS
New research could help doctors determine how severe a case of multiple sclerosis will become....
JUN 23, 2018
Microbiology
JUN 23, 2018
In a First, Keystone Virus Sickens a Person
A teenage boy in North Central Florida presented with symptoms that defied diagnosis....
JUL 12, 2018
Cardiology
JUL 12, 2018
Heart Attacks and Improving Heart Regeneration
A recent study has found that treatment with the protein, VEGF-C, improves healing and recovery of heart function after a heart attack....
JUL 20, 2018
Chemistry & Physics
JUL 20, 2018
X-ray Images to Get Colors
In the near future, the X-ray images from your doctor's office will no longer be just black and white, at least that's what MARS Bioimaging Ltd, an...
AUG 01, 2018
Cell & Molecular Biology
AUG 01, 2018
Levels of One Molecule, LAC, can Diagnose Depression
Depression can be hard to classify and therefore, challenging to treat. New work could help change that....
SEP 21, 2018
Clinical & Molecular DX
SEP 21, 2018
We will teach you to be a doctor, said us to the machine.
Clinical diagnosis are now possible in the hands of computers through machine learning. Whence, the reports of successful trials for the diagnostics....
Loading Comments...